.png)
BRIDGING THE GAP BETWEEN SCIENTIFIC KNOWLEDGE AND PRACTICAL APPLICATIONS
NECSOA specializes in neuroscience consulting services and the objective scientific assessment of structural and functional brain imaging data (MRI, DTI, fMRI, PET, EEG, MEG) using our custom solution Brain Integrity Check (BIC). We provide support in basic science and clinical domains and work with legal teams to bring high-quality neuroscientific knowledge, data, and analytics into the courtroom.
Click below to learn more about all our services and solutions.
Our team of experts brings the latest neuroscience advancements to our clients in legal, clinical, and research settings.
Legal Services: NECSOA provides comprehensive support for legal teams, in both civil and criminal settings, especially for the objective evaluation of mild Traumatic Brain Injury (TBI). Services include expert data collection, analyses, reporting, and testimony with reference to brain imaging, electrophysiology, symptom profiles, and clinical history. Magnetic resonance imaging protocols support (1) Volumetric assessment of T1-weighted images to identify brain atrophy; (2) Diffusion Tensor Imaging (DTI) with quantitative assessment of white matter integrity as indexed by fractional anisotropy (FA) and tractography; (3) Susceptibility Weighted Imaging (SWI) for identification of hemorrhagic lesions, and (4) T2-weighted and FLAIR evaluations for identification of other lesions. Electrophysiological assessments potentially include evaluations of event-related potentials and fields, quantitative electroencephalography with analyses of spectral and connectivity metrics (qEEG), and magnetoencephalography (MEG) with evaluation of epileptiform transients and dipolar slow waves indications of brain dysfunction. Our reports meet Rule 26 requirements and are based on objective data analyses supplemented with expert neuroscientific information and opinions.
Clinical Services: NECSOA provides advanced brain imaging and electrophysiological information to medical teams for guiding clinical care. Our services are especially relevant to neurosurgical planning for patients with epilepsy. They can also provide insight into conditions like TBI, PTSD, multiple sclerosis, Alzheimer’s disease, mild cognitive impairment, and autism spectrum disorders.
Research & Development: NECSOA, in conjunction with its sister and parent companies (CADET Scientific LLC and CADET NM Inc., respectively), provides support to clinicians, scientists, and industrial partners for neuroscientific research projects, especially for the co-development and testing of new therapeutic approaches to TBI, PTSD, tinnitus, and autism spectrum disorders, plus the development of data analysis pipelines for neuroimaging data.
Educational Outreach: NECSOA provides education for patients and their families, clinicians, scientists, students, and legal teams, on how imaging and electrophysiological assessments can aid in the evaluation and treatment of a range of brain conditions.
Read below about our Brain Integrity Check Platform for assessing brain structure and function in health, disease, and injury.
Brain Integrity Check (BIC) is our custom toolkit for data collection and quantitative analysis of advanced brain imaging data in relation to neurological and/or psychiatric disease and injury. There are three core offerings:
Our premier product, BIC-MRI, provides objective quantification of brain structure and injury using advanced Magnetic Resonance procedures, including volumetric assessment of brain atrophy and diffusion tensor imaging (DTI) assessment of white matter integrity. The MRI data are supplemented by a symptom self-report tool that is completed online. BIC-MRI is particularly valuable in legal cases involving traumatic brain injuries, mental health disorders, and cognitive impairments. BIC-MRI informs the structural-functional connection between brain damage and alterations in cognitive abilities and mental health. The results potentially provide objective evidence of brain compromise that can aid in assessing client circumstances. By delivering reliable data, BIC-MRI enhances the understanding of brain-related legal issues and supports informed decision-making in legal contexts.
This is an assessment package that includes self-report symptom screening tools, objective evaluation of eye movements and balance, and computerized cognitive testing to screen for problems in memory, attention, and executive skills. BIC-SS is ideal for early identification of clients with brain systems that are compromised by injury or disease. BIC-SS also aids in the early identification of pre-morbid or co-morbid non-TBI factors that can complicate the etiological interpretation of current imaging and/or physiological findings (e.g., factors such as a history of learning disability, substance abuse, major depressive disorder, or remote head trauma).
This package focuses on the collection and objective analyses of electrophysiological data on brain function, as obtained through magnetoencephalography (MEG) and/or electroencephalography (EEG). These methods are especially sensitive to different types of brain dysfunction and can be useful in the identification of conditions like TBI and epilepsy. In legal cases where a client is suspected of having a mild TBI, but the situation is complicated by multiple premorbid conditions, additional evaluation with these methods can play an instrumental role in the differential etiological evaluation of findings – that is, these types of data can sometimes help to rule out non-TBI factors as the cause of observed abnormalities.
NECSOA offers legal support in both civil and criminal cases where there are critical questions concerning neurological and/or psychiatric disease and injury, especially in relation to head trauma. We provide these two major services:
In civil cases, we most commonly work with plaintiff teams, but we can also provide support to defense teams with respect to an independent evaluation of the quality and integrity of MRI, DTI, EEG, and MEG evaluations performed by others. On the one hand, we are strong proponents for the presentation of high-quality neuroscientific data in the courtroom, but we also recognize that many other providers collect sub-par data, and/or perform low-quality (or even invalid) data analyses. We can aid in the recognition of these situations.
Have any questions about our services? Reach out to us for an initial no-cost consultation on a specific client, get a sample report, and learn more about our pricing structure.
Dr. Lewine is NECSOA's Founder, Chief Executive Officer, and Chief Scientific Officer. Dr. Lewine’s work involves behavioral, imaging, and electrophysiological methods (including MRI, DTI, MRS, SPECT, EEG, and MEG), to evaluate brain structure and function in health and disease. Over the years, he has received more than $10M in funding from a variety of Federal, State, and Philanthropic sources including, NIH, NSF, DoE, DoD, BARDA, the Robert Wood Johnson Foundation, Cure Autism Now, NARSAD, and the March of Dimes.
He has a doctoral degree in Neuroscience from the University of Rochester and was a Director’s Fellow in Biophysics and Neuroscience, at Los Alamos National Laboratory. He has been on the faculty of Universities in New Mexico, Kansas, Illinois, and Utah, with appointments in various departments including Neurology, Radiology, Psychology, Psychiatry, Computer Science, and Electrical and Computer Engineering.
Dr. Bangera is NECSOA's co-Founder, Chief Technology and Operation Officer. As the CTO, Dr. Bangera drives innovation in biosignal analysis, medical technology, product design, and data science at NECSOA. Dr. Bangera’s research has focused on developing new methodologies to analyze multimodal biomedical imaging data (including EEG, MEG, MRI, DTI, and OCT/A) and spans diverse areas, from brain imaging to neurophysiology.
He has a doctoral degree in Biomedical Engineering from Boston University and has previously worked as a research scientist at institutions such as the MIND Research Network and UCLA. His most recent work in the field of migraine led to an award-winning publication for discovering a reduction in perfusion during migraine attack with the aid of Optical Coherence Tomography Angiography.
Diana Reynoso is an accomplished professional with over 18 years of experience in operations and customer service. Diana excels in creating and implementing efficient processes and workflows to support the delivery of products and services.
She is proficient in various workflow and data management platforms and has extensive expertise in office operations, project planning and management, auditing, strategic planning, and customer service. Her experience in communications and operations management includes coordinating marketing and administrative functions to optimize productivity, managing accounting operations, and supporting public relations and event efforts. She has also led continuous marketing and communications initiatives and managed high-priority projects.
JEFFREY DAVID LEWINE, PH.D.
Whether you are exploring business and product development or require consulting or expert testimony in legal cases involving neuroscience, our team is ready to assist.
